edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

Avidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy
Stock NewsThemesAvidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy

Avidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy

Edgen StockEdgen Stock·Sep 12 2025, 04:00
Share to
Share to
Copy link
RNARNA+0.28%
Avidity Biosciences Advances Del-Zota Towards Accelerated FDA Approval for Duchenne Muscular Dystrophy
source:
[1] Avidity Biosciences: 'Strong Buy' Based On Accelerated Approval Filing For Del-Zota (RNA) (https://seekingalpha.com/article/4822205-avid ...)[2] Avidity Biosciences: Maintaining 'Strong Buy' Rating Based On Accelerated Approval Filing For Del-Zota - Seeking Alpha (https://seekingalpha.com/article/4636000-avid ...)[3] KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results (https://vertexaisearch.cloud.google.com/groun ...)

Related News

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live
Dec 21 2025, 11:28

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live

BlackSky Technology (BKSY) stock has gained 80.07% year-to-date after the successful deployment of its third Gen-3 satellite, which became commercially active three weeks after launch.

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls
Dec 21 2025, 07:04

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls

Google's dual-track AI strategy is validated as OpenAI's focus on complex models leads to a user growth bottleneck despite revenues surpassing $19 billion.

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets
Dec 21 2025, 06:44

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets

A CITIC Securities report highlights that China's record $1.076 trillion trade surplus is driving expectations for a sustained RMB appreciation, which is expected to boost profits for import-reliant industries.